Andeavor Logistics LP (ANDX) Analysts See $0.81 EPS; 24 Bullish Analysts Covering Vertex Pharmaceuticals (VRTX)

January 22, 2018 - By Marie Mckinney

Among 28 analysts covering Vertex Pharmaceuticals (NASDAQ:VRTX), 24 have Buy rating, 0 Sell and 4 Hold. Therefore 86% are positive. Vertex Pharmaceuticals had 81 analyst reports since July 31, 2015 according to SRatingsIntel. The firm has “Buy” rating by BTIG Research given on Friday, September 29. As per Friday, June 23, the company rating was upgraded by Needham. The stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) earned “Outperform” rating by Credit Suisse on Wednesday, January 20. The rating was maintained by Jefferies on Friday, June 9 with “Buy”. Jefferies maintained Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on Wednesday, October 5 with “Buy” rating. The rating was downgraded by H.C. Wainwright on Monday, October 24 to “Neutral”. Maxim Group maintained the shares of VRTX in report on Wednesday, July 19 with “Buy” rating. The firm has “Buy” rating by Citigroup given on Wednesday, March 1. The firm earned “Outperform” rating on Friday, June 2 by Oppenheimer. The stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) earned “Buy” rating by Jefferies on Wednesday, July 19. See Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) latest ratings:

05/01/2018 Broker: Bank of America Rating: Buy New Target: $180.0 Upgrade
02/01/2018 Broker: BMO Capital Markets Rating: Buy New Target: $184.0 Maintain
13/12/2017 Broker: Deutsche Bank Rating: Buy New Target: $175 Initiates Coverage On
12/12/2017 Broker: JMP Securities Rating: Buy New Target: $200.0 Maintain
26/10/2017 Broker: Needham Rating: Buy New Target: $195.0 Maintain
26/10/2017 Broker: Jefferies Rating: Buy New Target: $185.0 Maintain
26/10/2017 Broker: H.C. Wainwright Rating: Hold New Target: $85.0 Maintain
26/10/2017 Broker: Piper Jaffray Rating: Buy New Target: $205.0 Maintain
20/10/2017 Broker: BMO Capital Markets Rating: Buy New Target: $189.0 Maintain
18/10/2017 Broker: RBC Capital Markets Rating: Buy New Target: $181.0 Maintain




Analysts expect Andeavor Logistics LP (NYSE:ANDX) to report $0.81 EPS on February, 5.They anticipate $0.38 EPS change or 88.37% from last quarter’s $0.43 EPS. ANDX’s profit would be $177.64 million giving it 16.21 P/E if the $0.81 EPS is correct. After having $0.90 EPS previously, Andeavor Logistics LP’s analysts see -10.00% EPS growth. The stock increased 0.23% or $0.12 during the last trading session, reaching $52.52. About 432,805 shares traded. Andeavor Logistics LP (NYSE:ANDX) has 0.00% since January 22, 2017 and is . It has underperformed by 16.70% the S&P500.

Andeavor Logistics LP owns, operates, develops, and acquires logistics assets related to crude oil and refined products in the United States. The company has market cap of $11.52 billion. It operates in three divisions: Gathering, Processing, and Terminalling and Transportation. It has a 22.25 P/E ratio. The Gathering segment includes natural gas and crude oil pipeline gathering systems in the Bakken Shale/Williston Basin area of North Dakota and Montana; and the Green River Basin, Uinta Basin, and Vermillion Basin in the states of Utah, Colorado, and Wyoming.

Among 9 analysts covering Tesoro Logistics (NYSE:ANDX), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. Tesoro Logistics had 13 analyst reports since August 10, 2017 according to SRatingsIntel. The firm has “Overweight” rating given on Thursday, August 10 by Barclays Capital. The stock of Andeavor Logistics LP (NYSE:ANDX) has “Neutral” rating given on Friday, August 11 by Credit Suisse. Barclays Capital maintained the stock with “Overweight” rating in Friday, November 10 report. The stock of Andeavor Logistics LP (NYSE:ANDX) earned “Buy” rating by RBC Capital Markets on Sunday, October 15. The firm has “Hold” rating by Jefferies given on Monday, November 20. The rating was maintained by RBC Capital Markets with “Buy” on Monday, September 11. The stock has “Hold” rating by Mizuho on Thursday, November 9. The stock of Andeavor Logistics LP (NYSE:ANDX) earned “Buy” rating by Mitsubishi UFJ on Wednesday, August 16. Bank of America maintained Andeavor Logistics LP (NYSE:ANDX) on Wednesday, August 16 with “Buy” rating. Jefferies maintained Andeavor Logistics LP (NYSE:ANDX) on Monday, October 16 with “Hold” rating.

The stock increased 0.50% or $0.78 during the last trading session, reaching $157.97. About 2.09M shares traded or 33.57% up from the average. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has risen 45.69% since January 22, 2017 and is uptrending. It has outperformed by 28.99% the S&P500.

Vertex Pharmaceuticals Incorporated discovers, develops, makes, and commercializes medicines for serious diseases. The company has market cap of $39.95 billion. The firm focuses on developing and commercializing therapies for the treatment of cystic fibrosis and advancing its research and development programs. It has a 203.57 P/E ratio. It markets ORKAMBI (lumacaftor in combination with ivacaftor) for the treatment of patients with CF 12 years of age and older who have two copies (homozygous) of the F508del mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene; and KALYDECO (ivacaftor) for the treatment of patients with CF 2 years of age and older who have the G551D mutation or other specified mutations in their CFTR gene.

Investors sentiment increased to 1.62 in Q3 2017. Its up 0.11, from 1.51 in 2017Q2. It improved, as 32 investors sold Vertex Pharmaceuticals Incorporated shares while 151 reduced holdings. 79 funds opened positions while 217 raised stakes. 231.42 million shares or 0.04% more from 231.33 million shares in 2017Q2 were reported. Hirtle Callaghan And Limited Liability Company stated it has 0% of its portfolio in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Pictet Asset Management Ltd accumulated 1.03 million shares. Loring Wolcott & Coolidge Fiduciary Advsr Limited Liability Partnership Ma accumulated 0% or 625 shares. 4,767 are held by Livforsakringsbolaget Skandia Omsesidigt. 17,113 are held by Gsa Partners Llp. Clinton Group owns 3,545 shares for 0.06% of their portfolio. First Personal Finance has invested 0% of its portfolio in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). 199,378 are held by Public Employees Retirement Of Ohio. Meeder Asset Inc stated it has 12,508 shares. First Manhattan invested in 0% or 2,325 shares. Patten Grp Incorporated holds 0% or 1 shares. Oregon Employees Retirement Fund invested 0.07% in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Calamos Advisors reported 29,229 shares or 0.03% of all its holdings. Moreover, Essex Investment Management Co Ltd Liability Co has 1.13% invested in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Bb&T Corporation holds 11,106 shares or 0.03% of its portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.